Monitor subsequent Form 4 filings to confirm execution. This small insider sale is unlikely to move the stock. No change to investment thesis given strong analyst consensus.
Price Chart
Executive Summary
Officer Alane P. Barnes filed a Form 144 indicating intent to sell 62,500 shares of BioCryst Pharmaceuticals (BCRX), valued at approximately $596,250. The shares are from an option grant dated 2017. Given the relatively small size relative to market cap ($2.2B) and no apparent negative catalyst, the filing is routine.
Key Facts
- Reporting person: Alane P. Barnes (Officer)
- Proposed sale: 62,500 shares of common stock
- Estimated value: $596,250 (based on filing date price)
- Shares acquired via option granted on 12/20/2017
- Sale intended for cash; filed on 05/13/2026
Financial Impact
Approximately $596,250, representing ~0.027% of market cap
Risk Factors
- Potential for larger unannounced insider sales if this is part of a planned selling program
- No specific risk from this filing alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003553 |
| Document: 0001959173-26-003553-index.html | 0001959173-26-003553 |
| Document: 0001959173-26-003553.txt | 0001959173-26-003553 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $9.07 $10.17 | ▲ +12.13% | ▲ +12.73% | $8.09 (−10.86%) |
Jun 29, 2026 13w ago | 8-K | $9.55 $9.34 | ▼ −2.20% | ▼ −1.92% | $8.09 (−15.34%) |
Jun 12, 2026 15w ago | 8-K | $9.06 $9.91 | ▲ +9.38% | ▲ +10.13% | $8.09 (−10.76%) |
Jun 12, 2026 16w ago | Press Release | $8.70 $10.45 | ▲ +20.11% | ▲ +18.34% | $8.09 (−7.07%) |
May 19, 2026 19w ago | Insider Cluster | $8.74 $8.99 | ▲ +2.86% | ▲ +2.12% | $8.09 (−7.49%) |
May 13, 2026 20w ago | 144 | $9.60 $8.50 | ▼ −11.46% | ▼ −10.85% | $8.09 (−15.78%) |
May 6, 2026 21w ago | 8-K | $8.83 $8.25 | ▼ −6.57% | ▼ −9.35% | $8.09 (−8.44%) |
May 4, 2026 21w ago | 8-K | $9.20 $8.57 | ▼ −6.85% | ▼ −12.49% | $8.09 (−12.12%) |
Apr 23, 2026 23w ago | DEFA14A | $8.94 $8.37 | ▼ −6.38% | ▼ −10.40% | $8.09 (−9.56%) |
Apr 15, 2026 24w ago | Press Release | $9.44 $8.80 | ▼ −6.78% | ▼ −12.82% | $8.09 (−14.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access